Clinical Trial Update: Optimal Duration of Dual Antiplatelet Therapy After Drug-eluting Stent Implantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the optimal duration of dual antiplatelet therapy after drug-eluting stent implantation; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Ischemia
• Stent Thrombosis

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Coronary Artery Disease, Stent Thrombosis | Phase 4 | Status: COMPLETED